145 related articles for article (PubMed ID: 32553313)
21. Epidemiological and behavioural correlates of drug-resistant tuberculosis in a Tertiary Care Centre, Delhi, India.
Dzeyie KA; Basu S; Dikid T; Bhatnagar AK; Chauhan LS; Narain JP
Indian J Tuberc; 2019 Jul; 66(3):331-336. PubMed ID: 31439176
[TBL] [Abstract][Full Text] [Related]
22. Large gap between attitude and action in tuberculosis preventive treatment among tuberculosis-related healthcare workers in eastern China.
Wang F; Ren Y; Liu K; Peng Y; Chen X; Chen B; Jiang J
Front Cell Infect Microbiol; 2022; 12():991400. PubMed ID: 36275034
[TBL] [Abstract][Full Text] [Related]
23. Trend and treatment status of latent tuberculosis infection patients in Japan - Analysis of Japan TB Surveillance data.
Kawatsu L; Uchimura K; Ohkado A
PLoS One; 2017; 12(11):e0186588. PubMed ID: 29091917
[TBL] [Abstract][Full Text] [Related]
24. Management of latent tuberculosis infection in China: Exploring solutions suitable for high-burden countries.
Cui X; Gao L; Cao B
Int J Infect Dis; 2020 Mar; 92S():S37-S40. PubMed ID: 32114201
[TBL] [Abstract][Full Text] [Related]
25. Latent tuberculosis infection: recent progress and challenges in South Korea.
Jeon D
Korean J Intern Med; 2020 Mar; 35(2):269-275. PubMed ID: 32131570
[TBL] [Abstract][Full Text] [Related]
26. Latent Tuberculosis Infection Diagnostic and Treatment Cascade among Contacts in Primary Health Care in a City of Sao Paulo State, Brazil: Cross-Sectional Study.
Wysocki AD; Villa TC; Arakawa T; Brunello ME; Vendramini SH; Monroe AA; Kritski AL
PLoS One; 2016; 11(6):e0155348. PubMed ID: 27285720
[TBL] [Abstract][Full Text] [Related]
27. Cost-effectiveness of 3 months of weekly rifapentine and isoniazid compared with other standard treatment regimens for latent tuberculosis infection: a decision analysis study.
Doan TN; Fox GJ; Meehan MT; Scott N; Ragonnet R; Viney K; Trauer JM; McBryde ES
J Antimicrob Chemother; 2019 Jan; 74(1):218-227. PubMed ID: 30295760
[TBL] [Abstract][Full Text] [Related]
28. Acceptance of treatment for latent tuberculosis infection: prospective cohort study in the United States and Canada.
Colson PW; Hirsch-Moverman Y; Bethel J; Vempaty P; Salcedo K; Wall K; Miranda W; Collins S; Horsburgh CR;
Int J Tuberc Lung Dis; 2013 Apr; 17(4):473-9. PubMed ID: 23485381
[TBL] [Abstract][Full Text] [Related]
29. Latent TB infection in children and adolescents: Scientific rationale and programmatic management.
Viswanathan VK
Indian J Tuberc; 2023; 70 Suppl 1():S35-S38. PubMed ID: 38110258
[TBL] [Abstract][Full Text] [Related]
30. "If I've got latent TB, I would like to get rid of it": Derivation of the CARD (Constraints, Actions, Risks, and Desires) Framework informed by South African healthcare worker perspectives on latent tuberculosis treatment.
Nathavitharana RR; van der Westhuizen A; van der Westhuizen HM; Mishra H; Sampson A; Meintjes J; Nardell E; McDowell A; Theron G
PLoS One; 2021; 16(8):e0254211. PubMed ID: 34407070
[TBL] [Abstract][Full Text] [Related]
31. Contact screening and chemoprophylaxis in India's Revised Tuberculosis Control Programme: a situational analysis.
Banu Rekha VV; Jagarajamma K; Wares F; Chandrasekaran V; Swaminathan S
Int J Tuberc Lung Dis; 2009 Dec; 13(12):1507-12. PubMed ID: 19919768
[TBL] [Abstract][Full Text] [Related]
32. Latent tuberculosis infection: Opportunities and challenges.
Chee CBE; Reves R; Zhang Y; Belknap R
Respirology; 2018 Oct; 23(10):893-900. PubMed ID: 29901251
[TBL] [Abstract][Full Text] [Related]
33. Tuberculosis infection among young nursing trainees in South India.
Christopher DJ; Daley P; Armstrong L; James P; Gupta R; Premkumar B; Michael JS; Radha V; Zwerling A; Schiller I; Dendukuri N; Pai M
PLoS One; 2010 Apr; 5(4):e10408. PubMed ID: 20454447
[TBL] [Abstract][Full Text] [Related]
34. Insights into culturally appropriate latent tuberculosis infection (LTBI) screening in NSW: perspectives of Indian and Pakistani migrants.
Hall J; Kabir TM; Shih P; Degeling C
Aust N Z J Public Health; 2020 Oct; 44(5):353-359. PubMed ID: 32776658
[TBL] [Abstract][Full Text] [Related]
35. Latent Tuberculosis Cascade of Care Among Healthcare Workers: A Nationwide Cohort Analysis in Korea Between 2017 and 2018.
Min J; Kim HW; Choi JY; Shin AY; Kang JY; Lee Y; Myong JP; Jeong H; Bae S; Koo HK; Lee SS; Park JS; Yim HW; Kim JS
J Korean Med Sci; 2022 May; 37(20):e164. PubMed ID: 35607742
[TBL] [Abstract][Full Text] [Related]
36. Tuberculosis in medical doctors - a study of personal experiences and attitudes.
Naidoo A; Naidoo SS; Gathiram P; Lalloo UG
S Afr Med J; 2013 Jan; 103(3):176-80. PubMed ID: 23472695
[TBL] [Abstract][Full Text] [Related]
37. Adherence to nine-month isoniazid for latent tuberculosis infection in healthcare workers: a prospective study in a tertiary hospital.
Chung SJ; Lee H; Koo GW; Min JH; Yeo Y; Park DW; Park TS; Moon JY; Kim SH; Kim TH; Sohn JW; Yoon HJ
Sci Rep; 2020 Apr; 10(1):6462. PubMed ID: 32296096
[TBL] [Abstract][Full Text] [Related]
38. Intention of physicians to implement guidelines for screening and treatment of latent tuberculosis infection in HIV-infected patients in The Netherlands: a mixed-method design.
Evenblij K; Verbon A; van Leth F
BMC Public Health; 2016 Sep; 16(1):915. PubMed ID: 27585867
[TBL] [Abstract][Full Text] [Related]
39. Screening of health-care workers for latent tuberculosis infection in a Tertiary Care Hospital.
Janagond AB; Ganesan V; Vijay Kumar GS; Ramesh A; Anand P; Mariappan M
Int J Mycobacteriol; 2017; 6(3):253-257. PubMed ID: 28776523
[TBL] [Abstract][Full Text] [Related]
40. Completion rate of latent tuberculosis infection treatment in patients aged 65 years and older.
Noh CS; Kim HI; Choi H; Kim Y; Kim CH; Choi JH; Hyun IG; Baek MS
Respir Med; 2019 Oct; 157():52-58. PubMed ID: 31522030
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
